Abiopharma

🔍 Gallagher Daniel Martin Jr (Executive)

Company: Robinhood Markets, Inc. (HOOD)

Report Date: 2026-03-19

Detailed Transactions and Holdings:

• Acquired 131,282 shares of Restricted Stock Units (Derivative)
  Date: 2026-03-19 | Code: A | equity_swap_involved: 0 | shares_owned_after: 131,282.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2

Footnotes:

• F1: Restricted stock units ("RSUs") convert into Class A Common Stock on a one-for-one basis upon vesting and settlement.
• F2: On March 19, 2026, the Reporting Person was granted 131,282 RSUs under the Robinhood Markets, Inc. ("Robinhood") 2021 Omnibus Incentive Plan. One-sixteenth (1/16) of these RSUs are scheduled to vest on June 1, 2026, with the remainder scheduled to vest in fifteen (15) equal quarterly installments thereafter, in each case subject to the Reporting Person's continued service with Robinhood through the applicable vesting date and subject to accelerated vesting in certain circumstances.